Publication Information

{'id': 'https://openalex.org/W3072989489', 'doi': 'https://doi.org/10.1186/s43094-020-00074-6', 'title': 'Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors', 'display_name': 'Computational virtual screening and structure-based design of some epidermal growth factor receptor inhibitors', 'publication_year': 2020, 'publication_date': '2020-08-18', 'ids': {'openalex': 'https://openalex.org/W3072989489', 'doi': 'https://doi.org/10.1186/s43094-020-00074-6', 'mag': '3072989489'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1186/s43094-020-00074-6', 'pdf_url': 'https://fjps.springeropen.com/track/pdf/10.1186/s43094-020-00074-6', 'source': {'id': 'https://openalex.org/S2898388368', 'display_name': 'Future Journal of Pharmaceutical Sciences', 'issn_l': '2314-7245', 'issn': ['2314-7245', '2314-7253'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'doaj'], 'open_access': {'is_oa': True, 'oa_status': 'diamond', 'oa_url': 'https://fjps.springeropen.com/track/pdf/10.1186/s43094-020-00074-6', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5101973179', 'display_name': 'Muhammad Tukur Ibrahim', 'orcid': 'https://orcid.org/0000-0002-6146-5667'}, 'institutions': [{'id': 'https://openalex.org/I12789410', 'display_name': 'Ahmadu Bello University', 'ror': 'https://ror.org/019apvn83', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I12789410']}], 'countries': ['NG'], 'is_corresponding': True, 'raw_author_name': 'Muhammad Tukur Ibrahim', 'raw_affiliation_strings': ['Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria', 'institution_ids': ['https://openalex.org/I12789410']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017427535', 'display_name': 'Adamu Uzairu', 'orcid': 'https://orcid.org/0000-0002-6973-6361'}, 'institutions': [{'id': 'https://openalex.org/I12789410', 'display_name': 'Ahmadu Bello University', 'ror': 'https://ror.org/019apvn83', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I12789410']}], 'countries': ['NG'], 'is_corresponding': False, 'raw_author_name': 'Adamu Uzairu', 'raw_affiliation_strings': ['Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria', 'institution_ids': ['https://openalex.org/I12789410']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111658500', 'display_name': 'Sani Uba', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I12789410', 'display_name': 'Ahmadu Bello University', 'ror': 'https://ror.org/019apvn83', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I12789410']}], 'countries': ['NG'], 'is_corresponding': False, 'raw_author_name': 'Sani Uba', 'raw_affiliation_strings': ['Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria', 'institution_ids': ['https://openalex.org/I12789410']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5032573298', 'display_name': 'Gideon Adamu Shallangwa', 'orcid': 'https://orcid.org/0000-0002-0700-9898'}, 'institutions': [{'id': 'https://openalex.org/I12789410', 'display_name': 'Ahmadu Bello University', 'ror': 'https://ror.org/019apvn83', 'country_code': 'NG', 'type': 'education', 'lineage': ['https://openalex.org/I12789410']}], 'countries': ['NG'], 'is_corresponding': False, 'raw_author_name': 'Gideon Adamu Shallangwa', 'raw_affiliation_strings': ['Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria'], 'affiliations': [{'raw_affiliation_string': 'Department of Chemistry, Faculty of Physical Science, Ahmadu Bello University, P.M.B 1045, Zaria, Kaduna State, Nigeria', 'institution_ids': ['https://openalex.org/I12789410']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5101973179'], 'corresponding_institution_ids': ['https://openalex.org/I12789410'], 'apc_list': {'value': 0, 'currency': 'USD', 'value_usd': 0, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.713, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 15, 'citation_normalized_percentile': {'value': 0.69135, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 89, 'max': 90}, 'biblio': {'volume': '6', 'issue': '1', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10211', 'display_name': 'Computational Drug Discovery Methods', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/1703', 'display_name': 'Computational Theory and Mathematics'}, 'field': {'id': 'https://openalex.org/fields/17', 'display_name': 'Computer Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10211', 'display_name': 'Computational Drug Discovery Methods', 'score': 0.9985, 'subfield': {'id': 'https://openalex.org/subfields/1703', 'display_name': 'Computational Theory and Mathematics'}, 'field': {'id': 'https://openalex.org/fields/17', 'display_name': 'Computer Science'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T11845', 'display_name': 'Cancer therapeutics and mechanisms', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10417', 'display_name': 'Lung Cancer Treatments and Mutations', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/t790m', 'display_name': 'T790M', 'score': 0.9325675}, {'id': 'https://openalex.org/keywords/egfr-inhibitors', 'display_name': 'EGFR Inhibitors', 'score': 0.6206488}, {'id': 'https://openalex.org/keywords/adme', 'display_name': 'ADME', 'score': 0.5190616}], 'concepts': [{'id': 'https://openalex.org/C2777930144', 'wikidata': 'https://www.wikidata.org/wiki/Q25100112', 'display_name': 'T790M', 'level': 5, 'score': 0.9325675}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.8176483}, {'id': 'https://openalex.org/C2776256026', 'wikidata': 'https://www.wikidata.org/wiki/Q47912', 'display_name': 'Lung cancer', 'level': 2, 'score': 0.79113054}, {'id': 'https://openalex.org/C2777506169', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'EGFR inhibitors', 'level': 4, 'score': 0.6206488}, {'id': 'https://openalex.org/C103697762', 'wikidata': 'https://www.wikidata.org/wiki/Q4112105', 'display_name': 'Virtual screening', 'level': 3, 'score': 0.5597681}, {'id': 'https://openalex.org/C69366308', 'wikidata': 'https://www.wikidata.org/wiki/Q2272286', 'display_name': 'ADME', 'level': 3, 'score': 0.5190616}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.49422076}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.4617638}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.4576837}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.43280327}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.35339814}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.3395057}, {'id': 'https://openalex.org/C74187038', 'wikidata': 'https://www.wikidata.org/wiki/Q1418791', 'display_name': 'Drug discovery', 'level': 2, 'score': 0.28577998}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.23125952}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.21706998}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.1773212}, {'id': 'https://openalex.org/C2780580887', 'wikidata': 'https://www.wikidata.org/wiki/Q417824', 'display_name': 'Gefitinib', 'level': 4, 'score': 0.15902776}], 'mesh': [], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1186/s43094-020-00074-6', 'pdf_url': 'https://fjps.springeropen.com/track/pdf/10.1186/s43094-020-00074-6', 'source': {'id': 'https://openalex.org/S2898388368', 'display_name': 'Future Journal of Pharmaceutical Sciences', 'issn_l': '2314-7245', 'issn': ['2314-7245', '2314-7253'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://doaj.org/article/2f0a2cc6d5864b049c5ec3897ddebc56', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306401280', 'display_name': 'DOAJ (DOAJ: Directory of Open Access Journals)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1186/s43094-020-00074-6', 'pdf_url': 'https://fjps.springeropen.com/track/pdf/10.1186/s43094-020-00074-6', 'source': {'id': 'https://openalex.org/S2898388368', 'display_name': 'Future Journal of Pharmaceutical Sciences', 'issn_l': '2314-7245', 'issn': ['2314-7245', '2314-7253'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.88, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 27, 'referenced_works': ['https://openalex.org/W1970476748', 'https://openalex.org/W1992553266', 'https://openalex.org/W2008041424', 'https://openalex.org/W2017430527', 'https://openalex.org/W2088540000', 'https://openalex.org/W2096786080', 'https://openalex.org/W2138851777', 'https://openalex.org/W2146418087', 'https://openalex.org/W2176725923', 'https://openalex.org/W2276317671', 'https://openalex.org/W2552229243', 'https://openalex.org/W2586454386', 'https://openalex.org/W2587420003', 'https://openalex.org/W2593436234', 'https://openalex.org/W2607841247', 'https://openalex.org/W2789777939', 'https://openalex.org/W2793202663', 'https://openalex.org/W2811419390', 'https://openalex.org/W2848396597', 'https://openalex.org/W2890605354', 'https://openalex.org/W2903600395', 'https://openalex.org/W2904766068', 'https://openalex.org/W2905279133', 'https://openalex.org/W2948831670', 'https://openalex.org/W3000157125', 'https://openalex.org/W3029097021', 'https://openalex.org/W3102274840'], 'related_works': ['https://openalex.org/W4385680932', 'https://openalex.org/W4361214898', 'https://openalex.org/W3072989489', 'https://openalex.org/W3030729391', 'https://openalex.org/W2944067375', 'https://openalex.org/W2792211948', 'https://openalex.org/W2106937997', 'https://openalex.org/W2043552054', 'https://openalex.org/W2004741937', 'https://openalex.org/W1849518619'], 'abstract_inverted_index': {'Abstract': [0], 'Background': [1], 'The': [2, 27, 156, 217], 'foremost': [3], 'cause': [4, 87], 'of': [5, 33, 41, 49, 61, 78, 88, 245], 'cancer': [6, 13, 20, 25, 35, 43, 51, 63], 'mortality': [7, 52], 'worldwide': [8], 'was': [9, 82, 137, 249], 'lung': [10, 19, 24, 34, 62], 'cancer.': [11], 'Lung': [12], 'is': [14, 29, 75, 92], 'divided': [15], 'into': [16], 'small': [17], 'cell': [18, 23], 'and': [21, 45, 69, 143, 174, 188, 191, 239, 267], 'non-small': [22], '(NSCLC).': [26], 'latter': [28], 'the': [30, 42, 50, 56, 59, 86, 105, 207, 232, 236, 246, 255, 271, 292], 'main': [31], 'type': [32], 'that': [36, 283], 'account': [37], 'for': [38], 'about': [39, 47, 65], '90%': [40], 'issues': [44], 'estimate': [46], '25%': [48], 'each': [53], 'year': [54], 'in': [55, 235, 291], 'world.': [57], 'Among': [58], 'types': [60], 'with': [64, 149, 163, 167, 171, 176, 206], '1.5': [66], 'million': [67], 'patients': [68], 'less': [70], 'than': [71, 231, 254], '20%': [72], 'survival': [73], 'rate': [74], 'NSCLC.': [76, 89], 'Overexpression': [77], 'EGFR': [79, 98, 200, 220], 'tyrosine': [80, 130], 'kinase': [81, 131], 'recognized': [83], 'to': [84, 95, 101, 145, 186, 193, 225, 251, 276], 'be': [85, 194, 288], 'Therefore,': [90], 'there': [91], 'a': [93, 150, 212, 227], 'need': [94], 'develop': [96], 'more': [97, 253], 'inhibitors': [99, 117, 120, 202, 222], 'due': [100], 'drug-resistance': [102], 'development': [103], 'by': [104, 259], 'mutation.': [106], 'Result': [107], 'Computational': [108], 'virtual': [109], 'screening': [110], 'on': [111], 'some': [112], 'epidermal': [113], 'growth': [114], 'factor': [115], 'receptor': [116, 132], '(EGFR': [118, 129], 'L858R/T790M': [119, 201, 221], 'or': [121], 'NSCLC': [122], 'therapeutic': [123], 'agents)': [124], 'against': [125], 'their': [126, 154, 263], 'target': [127], 'protein': [128], 'pdb': [133], 'entry': [134], '3IKA': [135], ')': [136], 'performed': [138], 'via': [139], 'molecular': [140], 'docking': [141], 'simulation': [142], 'pharmacokinetics': [144], 'identify': [146], 'hit': [147, 157], 'compounds': [148, 158, 182, 248, 273, 286], 'promising': [151], 'affinity': [152, 210, 230], 'toward': [153], 'target.': [155], 'discovered': [159], 'were': [160, 183, 214, 223, 274], 'compound': [161, 204], '22': [162, 205], '−9.8': [164], 'kcal/mol,': [165, 169, 173], '24': [166], '−9.7': [168, 172], '17': [170], '19': [175], '−9.5': [177], 'kcal/mol': [178], 'respectively.': [179], 'These': [180], 'lead': [181], 'further': [184], 'subjected': [185], 'drug-likeness': [187], 'ADME': [189], 'prediction': [190], 'found': [192, 224, 250, 275], 'orally': [195], 'bioavailable.': [196], 'Six': [197], '(6)': [198], 'new': [199], 'using': [203], 'highest': [208], 'binding': [209, 229], 'as': [211], 'template': [213, 233], 'designed.': [215], 'Conclusion': [216], 'six': [218], 'newly': [219], 'have': [226, 277], 'better': [228], 'used': [234], 'designing': [237], 'process': [238], 'AZD9291': [240], '(the': [241], 'positive': [242], 'control).': [243], 'None': [244], 'designed': [247, 272, 285], 'violate': [252], 'permissible': [256], 'limit': [257], 'set': [258], 'RO5': [260], 'thereby': [261], 'predicting': [262], 'easy': [264], 'transportation,': [265], 'absorption,': [266], 'diffusion.': [268], 'More': [269], 'so,': [270], 'good': [278], 'synthetic': [279], 'accessibility': [280], 'which': [281], 'indicates': [282], 'these': [284], 'can': [287], 'easily': [289], 'synthesized': [290], 'laboratory.': [293]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3072989489', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 8}, {'year': 2021, 'cited_by_count': 4}], 'updated_date': '2024-12-26T00:44:39.751414', 'created_date': '2020-08-24'}